Private Wealth Management Group’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23K Hold
123
0.01% 346
2026
Q1
$12K Hold
123
﹤0.01% 474
2025
Q4
$9.8K Hold
123
﹤0.01% 519
2025
Q3
$5.75K Hold
123
﹤0.01% 738
2025
Q2
$4.53K Sell
123
-80
-39% -$3.07K ﹤0.01% 801
2025
Q1
$7.18K Buy
203
+57
+39% +$2.31K ﹤0.01% 588
2024
Q4
$6.39K Buy
146
+1
+0.7% +$50 ﹤0.01% 643
2024
Q3
$6.58K Buy
145
+12
+9% +$523 ﹤0.01% 617
2024
Q2
$5.16K Buy
133
+80
+151% +$2.99K ﹤0.01% 693
2024
Q1
$1.71K Buy
53
+17
+47% +$504 ﹤0.01% 1049
2023
Q4
$1.03K Buy
+36
New +$865 ﹤0.01% 1255

Other funds holding RVMD

Private Wealth Management Group's RVMD Position: Q2 2026 in Review

Private Wealth Management Group held its Revolution Medicines (RVMD) position steady in Q2 2026 at 123 shares worth $23K. The position accounts for 0.01% of the portfolio, ranked #346.

Private Wealth Management Group first reported a position in RVMD in Q4 2023 and has held it in 11 quarters since. 688 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Private Wealth Management Group held 123 shares of Revolution Medicines worth $23K as of Q2 2026.
  • Private Wealth Management Group left its Revolution Medicines share count unchanged in Q2 2026.
  • Revolution Medicines made up 0.01% of Private Wealth Management Group's portfolio in Q2 2026, its #346 holding.
  • Private Wealth Management Group first reported a position in Revolution Medicines in Q4 2023 and has held it in 11 quarters since.
  • 688 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.